MJNA - Medical Marijuana, Inc.
| Previous Close | 0.1040 |
| Open | 0.1035 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.1001 - 0.1039 |
| 52 Week Range | 0.0600 - 0.1900 |
| Volume | 6,738,920 |
| Avg. Volume | 7,365,051 |
| Market Cap | 330.664M |
| Beta | -0.33 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0450 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire•6 hours ago
The History Channel's Award-Winning Television Series "Innovations with Ed Begley Jr." Features Medical Marijuana, Inc.
SAN DIEGO , June 19, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States , today announced that it has garnered national news coverage ...
- InvestorPlace•yesterday
GW Pharmaceuticals’ New Drug Is a Step Toward Marijuana Legalization
The news that GW Pharmaceuticals PLC (ADR) (NASDAQ:GWPH) will soon see Epidiolex, the company’s experimental drug that treats epilepsy, is fantastic in and of itself. Here’s why Epidiolex’s approval should matter to everyone participating in the burgeoning cannabis industry and not just GWPH shareholders. The biggest problem facing the cannabis industry at the moment as it pertains to Cannabidiol (CBD), the main ingredient of Epidiolex, is that hemp-derived CBD is technically considered legal throughout the U.S. as a result of the Agricultural Act of 2014 and exempted from Drug Enforcement Administration (DEA) regulation under a 2006 law, while marijuana-derived CBD is only legal in 30 states and Washington, D.C.
- PR Newswire•5 days ago
Medical Marijuana, Inc. Applauds DEA's Recent Clarification on CBD; Company's Products Federally Legal
SAN DIEGO, June 14, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, announced today that the company applauds the Drug Enforcement Administration (DEA) for its recent statement on the legality of cannabidiol (CBD) -- which further clarifies that some CBD products, such as hemp-derived CBD products sold by Medical Marijuana, Inc., are legal to distribute freely throughout the United States and do not fall under the regulations of the Controlled Substances Act (CSA). "Products and materials that are made from the cannabis plant and which fall outside the CSA definition of marijuana (such as sterilized seeds, oil or cake made from the seeds, and mature stalks) are not controlled under the CSA.
- PR Newswire•6 days ago
Medical Marijuana, Inc. Subsidiary HempMeds® Announces Import Permits for First-Ever THC-Free CBD Product in Argentina
SAN DIEGO, June 13, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, subsidiary HempMeds® today announced the historic authorization of its Real Scientific Hemp Oil-X™ (RSHO-X™) cannabidiol (CBD) hemp oil product for import into Argentina. Argentina's National Administration of Medicines, Food and Medical Technology (ANMAT) has approved the product for import. "As a company of firsts, we're proud to offer the first THC-free CBD product in Argentina," said Medical Marijuana, Inc. CEO Dr. Stuart Titus.
- PR Newswire•7 days ago
Phyto Animal Health, Subsidiary of Medical Marijuana, Inc., Announces Partnership with Professional Rodeo Rider Jennifer Arnold and Husband Brad Arnold of 3 Doors Down
SAN DIEGO, June 12, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary Phyto Animal Health has announced a partnership with Professional Rodeo Star Jennifer Arnold and her husband Brad Arnold, lead singer of Grammy Award-nominated multi-platinum Mississippi rock band 3 Doors Down. Phyto Animal Health offers a line of cannabidiol (CBD) hemp oil supplements and hemp products targeted to cats, dogs and horses. CBD hemp oil has been researched by top veterinarians for cardiovascular, orthopedic and mental animal health.
- PR Newswire•12 days ago
Medical Marijuana, Inc. Subsidiary Kannaway® Announces May 2018 as the Largest Revenue Sales Month in Company History
SAN DIEGO , June 7, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that its subsidiary Kannaway® booked ...
- PR Newswire•13 days ago
Medical Marijuana, Inc. Subsidiary HempMeds® President, Latin America Speaks at International Cannabis Summit in Guanajuato, Mexico
SAN DIEGO, June 6, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that subsidiary HempMeds® President, Latin America Raul Elizalde spoke at the international cannabis seminar CannaMexico World Summit on May 30-31 at the San Cristobal Center in León Guanajuato, Mexico. There, Elizalde presented on the therapeutic benefits of cannabinoids and the work that HempMeds® Mexico has been doing to increase access to cannabidiol (CBD) in Mexico. Grace was diagnosed with a rare and severe form of childhood epilepsy called Lennox-Gastaut Syndrome (LGS) which triggers up to 400 seizures a day. Grace was the first patient to be granted special permission in 2015 to legally import CBD into Mexico.
- PR Newswire•14 days ago
Medical Marijuana, Inc. Subsidiary Phyto Animal Health Adds HempBone Bacon Apple Donuts to CBD Pet Product Line
SAN DIEGO , June 5, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , subsidiary Phyto Animal Health today announced its ...
- PR Newswire•20 days ago
Medical Marijuana, Inc. Applauds New Market Opportunities for CBD, United Nations World Health Organization Hosts 40th Expert Committee on Drug Dependence Meeting
SAN DIEGO , May 30, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , announced today that the company applauds the United ...
- PR Newswire•21 days ago
Medical Marijuana, Inc. CEO to Speak on Medical Cannabis Research at 5th Annual Cannabis World Congress and Business Expo in New York
SAN DIEGO, May 29, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that at the 5th Annual Cannabis World Congress and Business Expo (CWCBE), taking place in New York City from May 31-June 2, the company's Chief Executive Officer Dr. Stuart Titus will speak on medical cannabis and cannabidiol (CBD) research on May 31. Medical Marijuana, Inc. subsidiary HempMeds® will also be showing retail-ready cannabis products and exhibiting its line of CBD hemp oil products at the Expo in booth #100.
- PR Newswire•27 days ago
Medical Marijuana, Inc. Announces Q1 2018 as the Largest Sales Revenue Quarter in Company History: Shows Gross Revenue Increase Exceeding 190%
SAN DIEGO , May 23, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that the company and its subsidiaries ...
- PR Newswire•28 days ago
Dateline NBC Segment Features Medical Marijuana, Inc. Portfolio Company Kannalife Sciences
SAN DIEGO, May 22, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) announced today that portfolio company Kannalife Sciences, Inc. ("Kannalife"), a bio-pharmaceutical and phyto-medical company, was featured in a Dateline NBC segment discussing how their research on cannabidiol (CBD)-like molecules could potentially change the landscape for various ailments including chronic traumatic encephalopathy (CTE) and the opioid epidemic. The May 20, 2018, segment entitled "Growing Promise" took an in-depth look into Kannalife Sciences and their groundbreaking research investigating whether the Company's proprietary CBD-like molecules can help change the medical landscape and offer several new treatments for specific ailments. "We are honored to be featured in this Dateline NBC special and thankful to be able to educate people on the therapeutic benefits of cannabinoids and how companies like Kannalife are working to conduct the necessary research on cannabinoid-like molecules to bring new drugs to market," said Kannalife Sciences CEO Dean Petkanas.
- PR Newswire•last month
Medical Marijuana, Inc. Garners International News Coverage on Leading News and Pop Culture Website BuzzFeed
SAN DIEGO, May 17, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that it has garnered international news coverage on leading news and pop culture website BuzzFeed. A Guide" talks about the many health and wellness benefits of cannabidiol (CBD) and quotes Medical Marijuana, Inc. CEO Dr. Stuart Titus throughout on how CBD works and the research that is being done to provide evidence for its many uses. The top news and lifestyle website, which boasts an audience of over 18 million unique global monthly views, is targeted at millennial consumers, pop culture enthusiasts and busy professionals looking for an all-inclusive place to get their news.
- PR Newswire•last month
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces Sponsorship of International Medicinal Cannabis Seminar in Brazil
SAN DIEGO, May 16, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil is a main sponsor for the "A Look Into the Future" International Medicinal Seminar in Rio de Janeiro, Brazil, on May 18-19. HempMeds® Brasil was the first company authorized by ANVISA to import a cannabidiol (CBD)-based product into Brazil for those suffering from various specific medical conditions. "Our international presence is important to the future of the company because we want to show that we care about access to CBD around the world, not just in the U.S.," said Medical Marijuana, Inc. CEO Dr. Stuart Titus.
- PR Newswire•last month
Medical Marijuana, Inc. Subsidiary HempMeds® Garners National News Coverage in Top Wellness Magazine SHAPE
SAN DIEGO , May 15, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States , today announced that its subsidiary HempMeds® has garnered ...
- PR Newswire•last month
Medical Marijuana, Inc. Subsidiary HempMeds® Announces Partnership with Northshore Pharmacy to Sell Real Scientific Hemp Oil™ in Bermuda
SAN DIEGO , May 9, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States , today announced its subsidiary HempMeds® has partnered with ...
- PR Newswire•last month
Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New 'Cannabis Beauty' Skincare Line For European Market
SAN DIEGO, May 8, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary Kannaway® has introduced "Cannabis Beauty," a new line of anti-aging skincare products for its European customers. The collection is available to all citizens of European Union (EU) member nations as well as other countries outside of the EU. The products in the collection are made from proprietary formulas that are safe, effective and toxin-free.
- PR Newswire•2 months ago
Medical Marijuana, Inc. and Subsidiaries Announce April 2018 as the Largest Revenue Sales Month in Company History
SAN DIEGO , May 3, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that both the Company and its subsidiary ...
- PR Newswire•2 months ago
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Partnership with NFL Legend Christian "Nigerian Nightmare" Okoye
SAN DIEGO, May 2, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that NFL legend and former fullback for the Kansas City Chiefs, Christian "Nigerian Nightmare" Okoye, has become a spokesperson for its subsidiary Kannaway® to help spread awareness on the therapeutic benefits of cannabidiol (CBD) for athletes and those looking to lead a healthy, active lifestyle. "We're thrilled to work with Mr. Okoye and to continue the conversation about the benefits that athletes like him are experiencing from using CBD," said Kannaway CEO Blake Schroeder.
- PR Newswire•2 months ago
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Hosts Cannabis Symposium for Brazilian Doctors at Offices in San Diego
SAN DIEGO , May 1, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States , today announced that its subsidiary HempMeds® Brasil hosted ...
- PR Newswire•2 months ago
Medical Marijuana, Inc. Subsidiary Kannaway® Featured in Prosper Magazine for Innovative Approach to the CBD Industry
SAN DIEGO, April 26, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) announced today that its subsidiary Kannaway, LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has been featured in Prosper: Home-Based Business Solutions, a magazine dedicated to home businesses. In the April 2018 issue, Prosper spotlights Kannaway® and the company's executive team through a series of articles and interviews that demonstrate the company's dedication to success. The issue also features the company's lineup of CBD and hemp products, including the science behind CBD and its proprietary Bi-Bong herbal blends.
- PR Newswire•2 months ago
Men's Health Features Medical Marijuana, Inc. CEO in Article on Use of Cannabis for Workout Recovery
SAN DIEGO, April 25, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that it has garnered news coverage in top U.S. consumer publication Men's Health. The April 20, 2018, article, "What You Need to Know About Using Cannabis for Workout Recovery," provides a high-level overview of what to expect when using cannabis-based recovery products for workouts. The article features the author's interview with Medical Marijuana, Inc. CEO Dr. Stuart Titus and his commentary on the use of cannabis and cannabidiol (CBD), dubbing him "Doctor Cannabis." It also highlights the Company's research and various investments in the biotech sector.
- PR Newswire•2 months ago
Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New Hempy's® Brand, Including New Responsibly Sourced Hemp Clothing, Products and Accessories
SAN DIEGO, April 24, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), announced today that subsidiary Kannaway, LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has announced a new product line featuring Hempy's® brand of Responsibly Sourced Hemp Clothing and Accessories. The new line is now available for purchase in Kannaway®'s online store. "We are excited to be able to offer the Hempy's brand experience to Kannaway customers," said Kannaway® CEO Blake Schroeder. Hempy's® products are for the environmentally conscious consumer and are created by using responsibly sourced hemp and organic cotton textiles.
- PR Newswire•2 months ago
Medical Marijuana, Inc.'s CBD Products Discounted in Celebration of Cannabis Culture Holiday 4/20
SAN DIEGO , April 19, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States , today announced that it is excited to celebrate cannabis ...
- PR Newswire•2 months ago
Medical Marijuana, Inc. Reports Fourth Quarter and Year End 2017 Financial Results and Operational Highlights - Annual Revenue Increased 230% Over 2016
SAN DIEGO , April 18, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States , today announced financial results for the quarter ...